Disease and Therapy Review Cervical Cancer

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

 Angina (Angina Pectoris)-API Insights, 2014

Angina (Angina Pectoris)-API Insights, 2014

  • $ 1 250
  • Industry report
  • by Delve Insight
  • November 2014

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the ...

Industries: Pathology | Countries: United States, World, India, China, Asia, North America, Singapore, Europe, Japan

 Athlete%s Foot (Tinea Pedis)-API Insights, 2014

Athlete%s Foot (Tinea Pedis)-API Insights, 2014

  • $ 1 250
  • Industry report
  • by Delve Insight
  • November 2014

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the ...

Industries: Pathology | Countries: United States, World, India, China, Asia, North America, Singapore, Europe, Japan

 Epilepsy-API Insights, 2014

Epilepsy-API Insights, 2014

  • $ 1 250
  • Industry report
  • by Delve Insight
  • November 2014

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the ...

Industries: Pathology | Countries: United States, World, India, China, Asia, North America, Singapore, Europe, Japan

North America Autoimmune Diagnostics Market - Growth, Trends And Forecasts (2014 - 2019)

North America Autoimmune Diagnostics Market - Growth, Trends And Forecasts (2014 - 2019)

  • $ 3 000
  • Industry report
  • by Mordor Intelligence LLP
  • September 2014

North America autoimmune disease diagnostics market is estimated to reach $7.09 billion in 2020 from $5.504 billion in 2014 with a CAGR 5.24%. The term “autoimmune disease” refers to a varied group of illnesses that involve almost every human organ system. U.S being ...

Industries: Pathology | Countries: North America

North America Hernia Repair Market Outlook to 2020

North America Hernia Repair Market Outlook to 2020

  • $ 3 000
  • Industry report
  • by Global Data
  • July 2014
  • 92 pages

North America Hernia Repair Market Outlook to 2020 Summary GlobalData's new report, "North America Hernia Repair Market Outlook to 2020", provides key market data on the North America Hernia Repair market. The report provides value, in millions of US dollars, volume (in units) and average prices (in ...

Industries: Pathology | Countries: North America, Mexico, Canada, United States

North America Hernia Repair Procedures Outlook to 2020

North America Hernia Repair Procedures Outlook to 2020

  • $ 450
  • Industry report
  • by Global Data
  • July 2014
  • 223 pages

North America Hernia Repair Procedures Outlook to 2020 Summary GlobalData's new report, "North America Hernia Repair Procedures Outlook to 2020", provides key market data on the North America Hernia Repair Procedures. The report provides procedure volumes within market segments - Inguinal Hernia Repai ...

Industries: Pathology | Countries: United States, Mexico, Canada, North America

Buck Institute for Age Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Buck Institute for Age Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • April 2014
  • 18 pages

Summary Buck Institute for Research on Aging (Buck Institute) is a research and education center. The organization concentrates on extending the health-span, the healthy years of each individual's life. Buck Institute provides research to understanding the connection between aging and chronic disease. ...

Industries: Pathology | Countries: United States, North America

Humira (Ulcerative Colitis) - Forecast and Market Analysis to 2022

Humira (Ulcerative Colitis) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • February 2014
  • 48 pages

Humira (Ulcerative Colitis) - Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson's (J&J's) Simponi and Takeda's Entyvio, which will lead to an increase in the overall number of patients ...

Industries: Pathology | Countries: Japan, Canada, United States, Spain, Italy, France, Germany, World, Europe, United Kingdom, North America

Simponi (Ulcerative Colitis) - Forecast and Market Analysis to 2022

Simponi (Ulcerative Colitis) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • February 2014
  • 46 pages

Simponi (Ulcerative Colitis) - Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson's (J&J's) Simponi and Takeda's Entyvio, which will lead to an increase in the overall number of patients ...

Industries: Pathology | Countries: Canada, Japan, United States, Spain, Italy, France, Germany, World, United Kingdom, Europe, North America

Lialda (Ulcerative Colitis) - Forecast and Market Analysis to 2022

Lialda (Ulcerative Colitis) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • February 2014
  • 47 pages

Lialda (Ulcerative Colitis) - Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson's (J&J's) Simponi and Takeda's Entyvio, which will lead to an increase in the overall number of patients ...

Industries: Pathology | Countries: Canada, Japan, United States, Spain, Italy, Germany, World, United Kingdom, North America, Europe

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.